• Ticker

    Advertisement Find a Broker - Visit the DailyFinance Broker Center
DJIA 12,454.83 -74.92 -0.60%
NASDAQ 2,837.53 -1.85 -0.07%
S&P 500 1,317.82 -2.86 -0.22%

$62.51 -$0.59 (-0.94%)

REAL-TIME: Last trade at

Johnson & Johnson

NYSE:JNJ

Jump to this page for:

Related Resources

Is This Biotech's Best Stock?

5/27/2012 by DailyFinance

Have J&J's Approval Hopes Vanished?

5/26/2012 by DailyFinance

The Dow's 3 Biggest Losers This Week

5/26/2012 by DailyFinance

Biotechnology Stocks To Watch Ahead Of ASCO 2012: Part 4

5/26/2012 by Seeking Alpha

'Buy Zones' For The DIY Dividend Portfolio Part 3b: Healthcare

5/25/2012 by Seeking Alpha

Is This Dow Heavyweight a Value Trap?

5/25/2012 by DailyFinance

Emergent, Pfizer, Abbott Looking Strong In Their Fields

5/25/2012 by Trefis

Pipeline Setback for Bayer/JNJ - Analyst Blog

5/25/2012 by Nasdaq

Five Stocks Hedge Funds are Betting Against: the Short List from Goldman Sachs

5/25/2012 by YCharts

Building A Retirement Portfolio In A Tumultuous Time

5/25/2012 by Seeking Alpha

Shire Presents Data on Venvanse - Analyst Blog

5/24/2012 by Nasdaq

This Just In: Upgrades and Downgrades

5/24/2012 by DailyFinance

Johnson & Johnson: An Uncommon Opportunity

5/24/2012 by Seeking Alpha

Bayer Backs Xarelto Sales Forecast After FDA Panel Votes Against Expanded Use

5/24/2012 by Smart Money

Best of the Blogs, Biotech: Is an Anti-Obesity Drug Finally in Sight?

5/24/2012 by Minyanville

Gilead Drug Up for European Review - Analyst Blog

5/24/2012 by Nasdaq

Undervalued Leaders From Jeremy Grantham To Buy - Will You Let Them Pass By?

5/24/2012 by Seeking Alpha

Abbott Aims Pediatric Nutritional Market With New Beverage

5/24/2012 by Trefis

What's Better (for Commodity Investors) Than the Farmers' Almanac?

5/24/2012 by Minyanville

Shorter Timeframe, More Risky

5/24/2012 by DailyFinance

How High Can Pharmacyclics Fly?

5/23/2012 by DailyFinance

JNJ Updates: Imodium Recalls; Heading For Chinese Acquisitions; Zytiga’s Success

5/23/2012 by Trefis

Buy, Sell, or Hold: Johnson & Johnson

5/23/2012 by DailyFinance

Zacks' Voice of the People highlights opportunities with Johnson & Johnson, Disney, Abbott Labs and

5/23/2012 by Nasdaq

JNJ Updates: Positives For Xarelto & Simponi

5/23/2012 by Trefis

UPDATE: FDA Panel Votes Against Expanded Approval Of Bayer, J&J's Xarelto

5/23/2012 by Smart Money

Retirement Strategy: Remember All Of Our 'Dry Powder'? (Part 24)

5/23/2012 by Seeking Alpha

Is Bristol a Buy Post-Plavix

5/23/2012 by DailyFinance

Johnson & Johnson: Great Investment But Not For A Short-Term Price Rebound

5/23/2012 by Seeking Alpha

FDA Panel Votes Against Expanded Approval Of Bayer, J&J's Xarelto

5/23/2012 by Smart Money

Medivation Files Enzalutamide NDA - Analyst Blog

5/22/2012 by Nasdaq

4 Stocks Proving That Regulation Matters

5/22/2012 by DailyFinance

Prostate Cancer Companies Suffer When They Ignore Urologists

5/22/2012 by Minyanville

UK's NICE Gives Final OK for Bayer's Xarelto To Prevent Strokes

5/22/2012 by Smart Money

1 Great Dividend to Buy Today

5/22/2012 by DailyFinance

RobMarketsBlind's Latest Purchase - Voice of the People

5/22/2012 by Nasdaq

Johnson & Johnson's Xarelto Should Be Given to More Patients, FDA Staff Says

5/21/2012 by Minyanville

UPDATE: FDA Reviewer Backs Expanded Approval Of Bayer, J&J's Xarelto

5/21/2012 by Smart Money

Dendreon's Saving Grace

5/21/2012 by DailyFinance

J&J's Simponi Helps Colitis Patients In Clinical Trial

5/21/2012 by Smart Money
See More Articles...